vs
嘉德诺（BTSG）与希捷科技（STX）财务数据对比。点击上方公司名可切换其他公司
嘉德诺的季度营收约是希捷科技的1.1倍（$3.6B vs $3.1B），希捷科技净利率更高（24.0% vs 2.2%，领先21.9%），希捷科技同比增速更快（44.1% vs 16.3%），希捷科技自由现金流更多（$953.0M vs $193.9M），过去两年希捷科技的营收复合增速更高（28.4% vs 17.4%）
嘉德诺是美国跨国医疗服务企业，位列美国企业营收榜第15位，总部位于俄亥俄州都柏林。公司主营药品与医疗产品分销，服务覆盖超10万个网点，同时生产手套、手术服、流体管理产品等医用外科用品，还运营着规模位居前列的放射性药物网络。
希捷科技是全球知名的美国数据存储企业，1978年注册成立时名为舒加特科技，1979年正式开展业务，2010年起注册地变更为爱尔兰都柏林，运营总部设在美国加利福尼亚州弗里蒙特，面向全球市场提供专业的数据存储产品与解决方案。
BTSG vs STX — 直观对比
营收规模更大
BTSG
是对方的1.1倍
$3.1B
营收增速更快
STX
高出27.8%
16.3%
净利率更高
STX
高出21.9%
2.2%
自由现金流更多
STX
多$759.1M
$193.9M
两年增速更快
STX
近两年复合增速
17.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.6B | $3.1B |
| 净利润 | $77.1M | $748.0M |
| 毛利率 | 11.6% | 46.5% |
| 营业利润率 | 3.0% | 32.1% |
| 净利率 | 2.2% | 24.0% |
| 营收同比 | 16.3% | 44.1% |
| 净利润同比 | 381.8% | -23.8% |
| 每股收益（稀释后） | $0.34 | $3.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BTSGSTX
| Q3 26 | — | $3.1B | ||
| Q1 26 | — | $2.8B | ||
| Q4 25 | $3.6B | $2.6B | ||
| Q3 25 | $3.3B | — | ||
| Q2 25 | $3.1B | $2.4B | ||
| Q1 25 | $2.9B | $2.2B | ||
| Q4 24 | $3.1B | $2.3B | ||
| Q3 24 | $2.9B | $2.2B |
净利润BTSGSTX
| Q3 26 | — | $748.0M | ||
| Q1 26 | — | $593.0M | ||
| Q4 25 | $77.1M | $549.0M | ||
| Q3 25 | $55.8M | — | ||
| Q2 25 | $28.2M | $488.0M | ||
| Q1 25 | $29.5M | $340.0M | ||
| Q4 24 | $16.0M | $336.0M | ||
| Q3 24 | $-8.2M | $305.0M |
毛利率BTSGSTX
| Q3 26 | — | 46.5% | ||
| Q1 26 | — | 41.6% | ||
| Q4 25 | 11.6% | 39.4% | ||
| Q3 25 | 11.8% | — | ||
| Q2 25 | 11.9% | 37.4% | ||
| Q1 25 | 11.8% | 35.2% | ||
| Q4 24 | 13.8% | 34.9% | ||
| Q3 24 | 14.0% | 32.9% |
营业利润率BTSGSTX
| Q3 26 | — | 32.1% | ||
| Q1 26 | — | 29.8% | ||
| Q4 25 | 3.0% | 26.4% | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 1.5% | 23.2% | ||
| Q1 25 | 1.8% | 20.0% | ||
| Q4 24 | 2.6% | 21.0% | ||
| Q3 24 | 2.0% | 18.6% |
净利率BTSGSTX
| Q3 26 | — | 24.0% | ||
| Q1 26 | — | 21.0% | ||
| Q4 25 | 2.2% | 20.9% | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 0.9% | 20.0% | ||
| Q1 25 | 1.0% | 15.7% | ||
| Q4 24 | 0.5% | 14.5% | ||
| Q3 24 | -0.3% | 14.1% |
每股收益（稀释后）BTSGSTX
| Q3 26 | — | $3.27 | ||
| Q1 26 | — | $2.60 | ||
| Q4 25 | $0.34 | $2.43 | ||
| Q3 25 | $0.26 | — | ||
| Q2 25 | $0.13 | $2.24 | ||
| Q1 25 | $0.14 | $1.57 | ||
| Q4 24 | $0.11 | $1.55 | ||
| Q3 24 | $-0.04 | $1.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $88.4M | $1.1B |
| 总债务越低越好 | $2.5B | $3.9B |
| 股东权益账面价值 | $1.9B | — |
| 总资产 | $6.4B | $8.9B |
| 负债/权益比越低杠杆越低 | 1.34× | — |
8季度趋势，按日历期对齐
现金及短期投资BTSGSTX
| Q3 26 | — | $1.1B | ||
| Q1 26 | — | $1.0B | ||
| Q4 25 | $88.4M | $1.1B | ||
| Q3 25 | $140.3M | — | ||
| Q2 25 | $70.1M | $891.0M | ||
| Q1 25 | $52.3M | $814.0M | ||
| Q4 24 | $61.3M | $1.2B | ||
| Q3 24 | $36.0M | $1.2B |
总债务BTSGSTX
| Q3 26 | — | $3.9B | ||
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.7B | — |
股东权益BTSGSTX
| Q3 26 | — | — | ||
| Q1 26 | — | $459.0M | ||
| Q4 25 | $1.9B | $-63.0M | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.7B | $-453.0M | ||
| Q1 25 | $1.7B | $-829.0M | ||
| Q4 24 | $1.6B | $-1.1B | ||
| Q3 24 | $1.6B | $-1.3B |
总资产BTSGSTX
| Q3 26 | — | $8.9B | ||
| Q1 26 | — | $8.7B | ||
| Q4 25 | $6.4B | $8.4B | ||
| Q3 25 | $6.0B | — | ||
| Q2 25 | $5.9B | $8.0B | ||
| Q1 25 | $5.8B | $7.6B | ||
| Q4 24 | $5.9B | $8.0B | ||
| Q3 24 | $5.8B | $8.0B |
负债/权益比BTSGSTX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.34× | — | ||
| Q3 25 | 1.38× | — | ||
| Q2 25 | 1.45× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.58× | — | ||
| Q3 24 | 1.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $231.6M | $2.4B |
| 自由现金流经营现金流 - 资本支出 | $193.9M | $953.0M |
| 自由现金流率自由现金流/营收 | 5.5% | 30.6% |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | 3.00× | 3.17× |
| 过去12个月自由现金流最近4个季度 | $394.7M | — |
8季度趋势，按日历期对齐
经营现金流BTSGSTX
| Q3 26 | — | $2.4B | ||
| Q1 26 | — | — | ||
| Q4 25 | $231.6M | $532.0M | ||
| Q3 25 | $107.9M | — | ||
| Q2 25 | $49.1M | $508.0M | ||
| Q1 25 | $101.6M | $259.0M | ||
| Q4 24 | $90.6M | $221.0M | ||
| Q3 24 | $27.2M | $95.0M |
自由现金流BTSGSTX
| Q3 26 | — | $953.0M | ||
| Q1 26 | — | — | ||
| Q4 25 | $193.9M | $427.0M | ||
| Q3 25 | $92.2M | — | ||
| Q2 25 | $24.7M | $425.0M | ||
| Q1 25 | $84.0M | $216.0M | ||
| Q4 24 | $75.3M | $150.0M | ||
| Q3 24 | $7.2M | $27.0M |
自由现金流率BTSGSTX
| Q3 26 | — | 30.6% | ||
| Q1 26 | — | — | ||
| Q4 25 | 5.5% | 16.2% | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 0.8% | 17.4% | ||
| Q1 25 | 2.9% | 10.0% | ||
| Q4 24 | 2.5% | 6.5% | ||
| Q3 24 | 0.2% | 1.2% |
资本支出强度BTSGSTX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 4.0% | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.8% | 3.4% | ||
| Q1 25 | 0.6% | 2.0% | ||
| Q4 24 | 0.5% | 3.1% | ||
| Q3 24 | 0.7% | 3.1% |
现金转化率BTSGSTX
| Q3 26 | — | 3.17× | ||
| Q1 26 | — | — | ||
| Q4 25 | 3.00× | 0.97× | ||
| Q3 25 | 1.93× | — | ||
| Q2 25 | 1.74× | 1.04× | ||
| Q1 25 | 3.44× | 0.76× | ||
| Q4 24 | 5.66× | 0.66× | ||
| Q3 24 | — | 0.31× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BTSG
| Medicare D | $1.1B | 32% |
| Commercial Insurance | $879.8M | 25% |
| Medicare C | $641.2M | 18% |
| Provider Services | $394.2M | 11% |
| Medicaid | $301.4M | 8% |
| Medicare A | $150.5M | 4% |
| Private And Other | $44.0M | 1% |
| Medicare B | $19.5M | 1% |
| Pharmacy Solutions And Provider Services Segments | $19.0M | 1% |
STX
暂无分部数据
